At UCHealth University of Colorado Hospital, our LIPOSORBER (Lipid Apheresis) treatment is available, making it the only facility in Colorado and the surrounding region offering this potentially life-saving procedure. According to a recent American Heart Association study, lipid apheresis is a “valuable but underused” therapy for patients with severe cholesterol disorders such as familial hypercholesterolemia (FH).
Dr. David Saxon, medical director of lipid apheresis, emphasizes the treatment’s uniqueness, attracting patients from various states seeking to manage severe genetic cholesterol disorders. He describes lipid apheresis as akin to “an oil change for your blood,” essential for prolonging patients’ lives and preventing heart-related deaths.
We want to thank Dr. Saxon and our LIPOSORBER team for getting the education and awareness out there to the Aurora/Denver, Colorado area regarding this treatment for rare, genetic cholesterol disorders, such as FH and elevated Lp(a).
Read the full article and watch the interview with Dr. Saxon and patient here:
‘Valuable but underused’ treatment filters LDL out of patient’s bloodstream
LIPOSORBER Indications For Use (FH):
The LIPOSORBER® LA-15 System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma of the following high risk patient populations for whom diet has been ineffective and maximum drug therapy has been either ineffective or not tolerated:
Group A. Clinically diagnosed Familial Hypercholesterolemic Homozygotes with LDL-C > 500 mg/dL;
Group B. Clinically diagnosed Familial Hypercholesterolemic Heterozygotes with LDL-C ≥ 300 mg/dL;
Group C. Clinically diagnosed Familial Hypercholesterolemic Heterozygotes with LDL-C ≥ 70 mg/dL and either documented coronary artery disease or documented peripheral artery disease; and
Group D. Clinically diagnosed Familial Hypercholesterolemic Heterozygotes with lipoprotein(a) [Lp(a)] ≥60 mg/dL (or 130 nmol/L) and either documented coronary artery disease or documented peripheral artery disease.
For complete Instructions for Use and safety information, please visit: liposorber.com/liposorber-safety-info/
